Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by EquityInveston May 02, 2018 8:09pm

121 Views

Post# 27973615

RE:MedReleaf has also reportedly been in conversations with APH

I hope that Aphria does not buy LEAF, the acquirer's sp always suffer in acqusitions. LEAF's executive mgt and shareholders want to outsmart the big three - WEED, ACB & APH

Digital2018 wrote:
MedReleaf seeking buyer as cannabis industry consolidates: sources

MedReleaf Corp., an Ontario-based grower of medical marijuana, has contactedlarger industry players about a sale, sources told The Globe and Mail. The most serious of these discussions is being held with Aurora Cannabis Inc. If Aurora purchases MedReleaf it would create the largest cannabis company in Canada by market capitalization ahead of Ottawa’s plan to legalize recreational use of the drug later this year. A deal has not been finalized and it is uncertain if an agreement will be reached, but if one does get done it will be the most recent in a series of purchases by Aurora. MedReleaf has also reportedly been in conversations with Aurora’s rivals Canopy Growth Corp. and Aphria Inc. (for subscribers)